Mme Docteur VALERIE FARRENQ

Bibliographie

• Early TNFα-antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: The DESIR cohort.

  2014

  ArticleArthritis Care & Research = Arthritis Care and Research

• Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort.

  2013

  ArticleRheumatology

• Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort.

  2012

  ArticleAnnals of the Rheumatic Diseases

• Is interleukin-6 an appropriate target to treat spondyloarthritis patients refractory to anti-tnf therapy? A cross-sectional national survey.

  2012

  ArticleArthritis Research and Therapy

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

• CABINET DU DR VALERIE FARRENQ

  11 AVENUE VICTOR HUGO, 94100 Saint-Maur-des-Fossés

  Libéral
  50 m59 m59 m62 m

  © OpenStreetMap · Photos Wikimedia Commons (CC)

  📷 Street View ↗🗺️ Maps ↗OSM ↗

• GHU APHP HM SITE HENRI MONDOR

  51 Avenue MAL DE LATTRE DE TASSIGNY, 94010 Créteil

  ☎ 0149812111Hospitalier🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data

  The Journal of rheumatology · 2005

  📚 58 citations🎯 RCR 1.77🩺 Clinique
• 2

  Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies

  The Journal of rheumatology · 2006

  📚 36 citations🎯 RCR 1.21
• 3

  Prevalence and factors associated with uveitis in spondylarthritis patients in France: results from an observational survey

  Arthritis care & research · 2012

  📚 33 citations🎯 RCR 1.28

  Lire l'abstract Crossref ↓

  AbstractObjectiveTo accurately estimate the prevalence of and the factors associated with uveitis in spondylarthritis (SpA) patients in France.MethodsIn an observational survey of SpA patients (diagnosis confirmed by the European Spondylarthropathy Study Group and/or Amor's criteria) consulting their rheumatologist for routine followup, we collected information regarding present/past history of uveitis, as well as detailed characteristics of the disease. Factors independently associated with uveitis were determined.ResultsFrom September 2008 to January 2009, 202 rheumatologists participated in the survey and recruited 902 patients (61% men) with a mean ± SD age of 45.3 ± 13.4 years and a mean ± SD disease duration of 10.4 ± 9.6 years. The SpA diagnoses were ankylosing spondylitis (71%), psoriatic arthritis (18%), or other SpA (11%). The HLA–B27 positivity rate was 76%. Uveitis prevalence was 32.2% (95% confidence interval [95% CI] 29.1–35.3%) since psoriasis and inflammatory bowel disease were 22.3% (95% CI 19.5–25.0%) and 8.6% (95% CI 6.7–10.5%), respectively. Recurrence of uveitis occurred in 52.3% and complications occurred in 11.7% of patients. Factors independently associated with uveitis were HLA–B27 positivity (adjusted odds ratio [ORadj] 2.97 [95% CI 1.83–4.81], P < 0.0001) and disease duration (ORadj 1.28 [95% CI 1.16–1.41], P < 0.0001 for ≥10 years).ConclusionResults indicate that uveitis is the most common extraarticular feature of SpA, occurring preferentially in HLA–B27–positive patients over the entire course of the disease.

Publications scientifiques (12) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche